RewordedRisk Factors
In periods when the market prices for our products are falling rapidly, including in response to falling market prices for raw materials, we have in the past, and it is possible that in the future we could be required to write-down the value of our inventories if market prices fall below our costs.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedRisk Factors
International Trade Commission’s (“ITC”) determination that the imports materially injured the U.S. phosphate fertilizer industry.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedRisk Factors
These facilities include our phosphate mines and concentrates plants; our potash mines; and the ports and other distribution facilities through which we, Canpotex and the other joint ventures in which we participate, conduct our respective businesses, as well as other commercial arrangements with unrelated third parties.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedRisk Factors
Denial or delay by a government agency in issuing any of our permits and approvals or imposition of restrictive conditions on us with respect to these in those permits and approvals may impair our business and operations.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedMD&A
The table below provides information about Mosaic’s significant foreign exchange derivatives.As of December 31, 2024 2025 As of December 31, 2023 2024 Expected Fair Expected Fair Maturity Date Value Maturity Date Value Years ending Years ending December 31, December 31, (in millions) 2026 2027 2028 2025 2026 2027 2024 2025 2026 Foreign Currency Exchange Forwards Canadian Dollar $ 2.4 $ (32.6) $ 15.5 Notional (million US$) - short Canadian dollars $ 51.6 — $ $ $ 297.3 51.6 $ — $ Weighted Average Rate - Canadian dollar to U.S. dollar 1.3771 — — 1.3387 — 1.3771 — — Notional (million US$) - long Canadian dollars $ 638.3 181.1 $ $ $ 1,068.5 638.3 $ 120.5 $ Weighted Average Rate - Canadian dollar to U.S. dollar 1.3859 — — 1.3504 — — 1.3430 1.3445 — Indian Rupee $ — 0.5 $ — Notional (million US$) - short Indian rupee $ 2.0 42.0 $ $ $ — 2.0 $ — $ Weighted Average Rate - Indian rupee to U.S. dollar 84.0382 89.0340 — — — 84.0382 — — Foreign Currency Exchange Non-Deliverable Forwards Brazilian Real $ (1.4) $ (51.2) $ 14.6 Notional (million US$) - long Brazilian real $ 563.4 95.0 $ $ $ 741.7 563.4 $ — $ Weighted Average Rate - Brazilian real to U.S. dollar 5.8279 5.6132 — — 5.0023 5.8279 — — Indian Rupee $ — $ 1.1 $ (0.3) Notional (million US$) - short Indian rupee $ 89.1 28.8 $ $ $ 80.0 89.1 $ — $ Weighted Average Rate - Indian rupee to U.S. dollar 84.7720 90.1810 — — 83.7458 84.7720 — — China Renminbi $ (0.5) $ 0.1 $ (1.4) Notional (million US$) - short China renminbi $ 33.0 86.4 $ $ $ 110.7 33.0 $ — $ Weighted Average Rate - China renminbi to U.S. dollar 7.1923 7.0585 — — 7.1336 7.1923 — — Total Fair Value $ 1.0 $ (82.6) $ 28.4
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedMD&A
Receivables, net 75.7 59.2 526.3 (215.2) Inventories, net (761.5) (275.6) 1,061.4 (749.6) Other current assets and noncurrent assets 8.1 (79.2) (239.2) (247.4) Accounts payable and accrued liabilities (359.6) 96.4 (1,055.1) 219.8 Other noncurrent liabilities 76.0 220.3 108.3 (0.1) Net cash provided by operating activities 824.8 1,299.2 2,407.2 3,935.8 Cash Flows from Investing Activities Capital expenditures (1,359.4) (1,251.8) (1,402.4) (1,247.3) Purchases of available-for-sale securities - restricted (975.6) (1,529.7) (1,240.8) (762.5) Proceeds from sale of available-for-sale securities - restricted 949.1 1,501.1 1,209.1 743.0 Proceeds from sale of business — — 158.4 — Acquisition of business — — (41.0) — Proceeds from sale of assets 79.0 16.8 4.8 Other 19.4 (0.5) 7.2 (2.6) 2.6 (5.3) Net cash used in investing activities (1,309.5) (1,261.0) (1,317.2) (1,259.6) Cash Flows from Financing Activities Payments of short-term debt (16,471.4) (16,779.6) (9,832.0) (1,761.2) Proceeds from issuance of short-term debt 16,282.6 17,032.8 10,007.1 1,980.5 Payments from inventory financing arrangement (2,005.8) (1,805.0) (601.4) (1,651.5) Proceeds from inventory financing arrangement 2,106.5 2,004.5 601.4 1,348.8 Payments of structured accounts payable arrangements (906.1) (755.0) (1,432.9) (1,476.6) Proceeds from structured accounts payable arrangements 961.8 737.3 1,048.2 1,460.5 Collections of transferred receivables 572.5 425.5 1,468.6 2,352.1 Payments of transferred receivables (572.5) (425.5) (1,468.6) (2,433.2) Payments of long-term debt (73.4) (67.2) (995.3) (610.3) Proceeds from issuance of long-term debt 904.7 70.3 900.0 — Repurchases of stock — (235.4) (756.0) (1,665.2) Cash dividends paid (280.4) (270.7) (351.6) (197.7) Dividends paid to non-controlling interest (20.2) (31.9) (41.5) (38.0) Other (46.3) (32.0) (26.5) 13.1 Net cash used in provided by (used in) financing activities 452.0 (131.9) (1,480.5) (2,678.7) Effect of exchange rate changes on cash 26.3 37.9 (2.8) (29.7) Net change in cash, cash equivalents and restricted cash (6.4) (55.8) (393.3) (32.2) Cash, cash equivalents and restricted cash—beginning of year 305.0 360.8 754.1 786.3 Cash, cash equivalents and restricted cash—end of year $ 298.6 $ 305.0 $ 360.8 $ 754.1
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedMD&A
The following table represents a comparison of the net cash provided by operating activities, net cash used in investing activities and net cash used in financing activities for calendar years 2024, 2023 2025, 2024 and 2022:Years Ended December 31, (in millions) 2024-2023 2023-2022 Cash Flow 2024 2023 2022 Change Percent Change Percent Net cash provided by operating activities $ 1,299.2 $ 2,407.2 $ 3,935.8 $ (1,108.0) (46)% $ (1,528.6) (39)% Net cash used in investing activities (1,261.0) (1,317.2) (1,259.6) 56.2 4% (57.6) (5)% Net cash used in financing activities (131.9) (1,480.5) (2,678.7) 1,348.6 91% 1,198.2 45% 2023:
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedMD&A
Depreciation, depletion and amortization 1,049.9 1,025.5 960.6 933.9 Deferred and other income taxes 251.8 (142.9) (261.2) 344.4 Equity in net (earnings) of nonconsolidated companies, net of dividends 0.6 (55.7) (31.8) (191.5) Accretion expense for asset retirement obligations 129.7 111.2 96.1 81.6 Amortization of debt financing fees 43.0 36.5 21.4 7.2 Share-based compensation expense 30.7 31.8 33.0 27.9 Impairment of goodwill 99.9 — — Unrealized (gain) loss on derivatives (85.7) 104.1 (29.0) 4.3 Foreign currency adjustments (267.1) 462.7 (94.0) (67.9) (Gain) loss Loss (gain) on sale of securities (2.4) 19.4 46.6 assets sold and to be sold 157.3 — (56.5) Pension settlement loss — — 42.4 41.9 Gain on sale of business — (56.5) — Gain on sale of equity investment — (538.2) — — Unrealized (gain) loss on equity securities (317.4) (28.3) — — Other 71.8 95.9 85.7 118.0 69.4 115.3 Changes in assets and liabilities:
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedMD&A
Years Ended December 31, 2025 2024 2023 2022 Net sales $ 12,052.4 $ 11,122.8 $ 13,696.1 $ 19,125.2 Cost of goods sold 10,150.5 9,610.9 11,485.5 13,369.4 Gross margin 1,901.9 1,511.9 2,210.6 5,755.8 Selling, general and administrative expenses 533.9 496.9 500.5 498.0 Loss (gain) on assets sold and to be sold 157.3 — (56.5) Impairment of goodwill 99.9 — — Other operating expenses 289.3 393.5 372.0 472.5 428.5 Operating earnings 821.5 621.5 1,338.1 4,785.3 Interest expense, net (187.7) (182.8) (129.4) (137.8) Foreign currency transaction gain (loss) gain 271.7 (685.8) 194.0 97.5 Gain on sale of equity investment — 522.2 — — Other income (expense) 307.4 40.3 (76.8) (102.5) Earnings from consolidated companies before income taxes 1,212.9 315.4 1,325.9 4,642.5 Provision for income taxes 639.8 186.7 177.0 1,224.3 Earnings from consolidated companies 573.1 128.7 1,148.9 3,418.2 Equity in net earnings of nonconsolidated companies 2.3 73.3 60.3 196.0 Net earnings including noncontrolling interests 575.4 202.0 1,209.2 3,614.2 Less:
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedMD&A
Preferred stock, $0.01 par value, 15,000,000 shares authorized, none issued and outstanding as of December 31, 2025 and 2024 and 2023 — — Common stock, $0.01 par value, 1,000,000,000 shares authorized, 395,125,254 shares issued and 317,408,647 shares outstanding as of December 31, 2025, 394,648,654 shares issued and 316,932,047 shares outstanding as of December 31, 2024, 393,875,241 shares issued and 324,103,141 shares outstanding as of December 31, 2023 2024 3.2 3.2 Capital in excess of par value 29.2 2.1 — Retained earnings 14,184.4 13,926.1 14,241.9 Accumulated other comprehensive loss (2,131.9) (2,449.0) (1,954.9) Total Mosaic stockholders’ equity 12,084.9 11,482.4 12,290.2 Non-controlling interests 149.3 132.3 142.6 Total equity 12,234.2 11,614.7 12,432.8 Total liabilities and equity $ 24,480.1 $ 22,924.0 $ 23,032.8
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedMD&A
Distribution operations in India and China had revenues and gross margin of $640.0 million and $88.0 million, respectively, for the year ended December 31, 2025, compared to revenues and gross margin of $519.6 million and $39.7 million, respectively, for the year ended December 31, 2024, compared to revenues and gross margin of $898.9 million and $(16.8) million, respectively, for the year ended December 31, 2023. 2024.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedMD&A
As of October 31, 2024, the date of Based on our annual impairment testing, the Company concluded quantitative analysis, we determined that the fair values of the reporting units which include goodwill, Potash, Mosaic Fertilizantes our Potash and Corporate, Eliminations and Other, reporting units were in substantial excess of their respective carrying values and the goodwill for those units was not impaired.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedMD&A
Net income for the year ended December 31, 2024 2025 was unfavorably favorably impacted by a foreign currency transaction loss gain of $686 $271.7 million, compared to a foreign currency transaction gain loss of $194 $685.8 million in the prior year period. period and an unrealized mark-to-market gain of approximately $317.0 million on the investment in Ma’aden shares, included in other income (expense).
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedMD&A
The Corporate, Eliminations and Other category includes the results of the China and India distribution businesses, intersegment eliminations, including profit on intersegment sales, unrealized mark-to-market gains and losses on derivatives and the investment in equity securities of Ma'aden, debt expenses, corporate functional costs and the results of the China and India distribution businesses. expenses.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedMD&A
The Corporate, Eliminations and Other category includes the results of the China and India distribution businesses, intersegment eliminations, including profit on intersegment sales, unrealized mark-to-market gains and losses on derivatives and the investment in equity securities of Ma'aden, debt expenses, corporate functional costs and the results of the China and India distribution businesses. expenses.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedMD&A
Cash and cash equivalents $ 276.6 $ 272.8 $ 348.8 Receivables, net 1,078.6 1,113.3 1,269.2 Inventories 3,363.0 2,548.4 2,523.2 Assets held for sale 73.5 — Other current assets 445.8 563.8 603.8 Total current assets 5,237.5 4,498.3 4,745.0 Property, plant and equipment, net 13,982.6 13,352.6 13,585.4 Equity securities and investments in nonconsolidated companies 1,848.2 1,533.4 909.0 Goodwill 1,005.1 1,061.1 1,138.6 Deferred income taxes 811.6 958.3 1,079.2 Other assets 1,595.1 1,520.3 1,575.6 Total assets $ 24,480.1 $ 22,924.0 $ 23,032.8 Liabilities and Equity Current liabilities:
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new